Testimony and CorrespondenceThrough its committees on Practice, Government Affairs, and Scientific Affairs, ASH formulates positions on pending federal legislation, regulations, and private insurance developments, which are communicated through congressional testimony and formal correspondence. In addition, ASH may submit comments to other organizations and governing bodies on issues related to research, practice, training, or quality of care issues affecting hematologists and their patients.
ASH Signs on to Letter Led by NMDP Requesting Safe and Timely Transport of Life-Saving Products Apr 09, 2020
ASH Issues Statement to the House Appropriations Labor-HHS Subcommittee on FY 2021 Funding Mar 25, 2020
ASH Comments on NIH Data Sharing Policy Jan 15, 2020
ASH Letter re: FDA’s Draft Guidance for Industry on Inclusion of Older Adults in Cancer Clinical Trials May 12, 2020
ASH and ASTCT Send Letter to CMS Regarding Options for CAR-T Inpatient Payment for FY2021 Nov 06, 2019